TRANSRADIAL UFE WITH HYDROPEARL™ MICROSPHERES
Uterine fibroids account for 30% of the 600,000 women who undergo hysterectomies annually.1 Uterine fibroid embolization (UFE) is a minimally invasive alternative to hysterectomy or myomectomy.
TREAT MORE PATIENTS7
Easier access site management
Reach visceral anatomy and beyond with longer access products
Patient-preferred
INCREASE EFFICIENCIES7
Allows for same-day-discharge
Reduce costs and improve procedure time
Ease of access to vessel origins from above
REDUCE PROCEDURAL COMPLICATIONS7
Less bleeding complications at the access site
Low risk for stroke
No reliance on internal closure device
TransRadial Artery Access (TRA) is proven to reduce associated bleeding and vascular complications. Using TRA in embolization procedures conveys proven benefits such as same day discharge opportunities, reduction in major bleeding complications, a readily accessible and easy to manage access site, and improved patient satisfaction.2-5
Terumo Interventional Systems is equipped to support your UFE procedure from access to embolization to closure.
Transradial UFE with Hydropearl™ Microspheres
Keep your patients in mind as you embolize. The unique formulation of HydroPearl™ Microspheres was exclusively developed to offer controlled and targeted embolization. HydroPearl™ Microspheres are tightly calibrated and indicated for embolization of uterine fibroids. This precise calibration may allow more predictable and targeted embolization.6-8
Explore comprehensive radial access and closure options to guide your approach to uterine artery embolization.
Terumo Interventional Systems is the pioneer in radial access with customized solutions that deliver economic value for providers and enhanced outcomes for their patients.
RESOURCES
DOCUMENTS
Need More Information?
We can help.
REFERENCES
- Gonsalves C. Uterine artery embolization for treatment of symptomatic fibroids. Semin Intervent Radiol. 2008;25(4):369-377. doi:10.1055/s-0028-1103001.
- Schussler JM. Effectiveness and safety of transradial artery access for cardiac catheterization. Proc (Bayl Univ Med Cent). 2011; 24(3):205-209.
- Marso SP, et al. National Cardiovascular Data Registry. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010 Jun 2;303(21):2156-64. doi: 10.1001/jama.2010.708. PMID: 20516416.
- Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol. 2001;13(5):354-362.
- Valgimigli M, et al. MATRIX Trial. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomized multicenter trial. Lancet. 2015;385:2465-76.
- PD111835 Rev. C PM-08035 Revised 2021-11.
- Data on file.
- Karolin J. Paprottka et al In-vitro-study of physical properties of various embolization particles regarding morphology before, during and after catheter passage. Clinical Hemorheology and Microcirculation. 1386-0291/16.





